GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » Price-to-Operating-Cash-Flow

Lipigon Pharmaceuticals AB (OSTO:LPGO) Price-to-Operating-Cash-Flow : (As of May. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB Price-to-Operating-Cash-Flow?

As of today (2024-05-20), Lipigon Pharmaceuticals AB's share price is kr0.354. Lipigon Pharmaceuticals AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.07. Hence, Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:LPGO's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 27.11
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Lipigon Pharmaceuticals AB's Cash Flow from Operations per share for the three months ended in Dec. 2023 was kr-0.05. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.07.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -16.50% per year.

During the past 6 years, Lipigon Pharmaceuticals AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.30% per year. The lowest was -122.80% per year. And the median was -68.00% per year.


Lipigon Pharmaceuticals AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB Price-to-Operating-Cash-Flow Chart

Lipigon Pharmaceuticals AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - - - -

Lipigon Pharmaceuticals AB Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow falls into.



Lipigon Pharmaceuticals AB Price-to-Operating-Cash-Flow Calculation

Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.354/-0.066
=

Lipigon Pharmaceuticals AB's Share Price of today is kr0.354.
Lipigon Pharmaceuticals AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Lipigon Pharmaceuticals AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Traded in Other Exchanges
Address
Tvistevagen 48 C, Umea, SWE, 90736
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines